NCT04675060View on ClinicalTrials.gov

Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
Advanced Solid Tumors
Interventions
DRUG

TQ-B3139 capsules

TQ-B3139 capsules administered 600mg orally, twice daily in 28-day cycle.

Trial Locations (1)

410000

RECRUITING

Hunan Cancer Hospital, Changsha

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY